This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Miltenyi Biotec
product type :
antibody
product name :
CD51/CD61 Antibody, anti-human, FITC
catalog :
130-103-678
quantity :
100 tests in 1 mL
price :
264 USD
clonality :
monoclonal
host :
mouse
conjugate :
FITC
clone name :
23C6
The same clone is also sold as:
The same clone is also sold as:
- R&D Systems: FAB3050A, FAB3050G, MAB3050, FAB3050P
- BD Biosciences: 555504, 562165, 550037, 555505
- OriGene: SM1135P, SM1135PS
- Abcam: ab20143
- BioLegend: 304406, 304402, 304418, 304416, 304415, 304412, 304403, 304417, 304408, 304404, 304410
- Santa Cruz Biotechnology: sc-7312
- Invitrogen: 14-0519-82, 13-0519-82, 11-0519-41, 11-0519-42, MA1-33578, MA5-16470, 16-0519-81
- Bio-Rad: MCA757GA, MCA757G
- Novus Biologicals: NB100-2677, NBP2-80816
reactivity :
human
application :
immunohistochemistry, immunocytochemistry, flow cytometry
product information
MB Cataloge Number :
130-103-678
Catalog Number :
130-103-678
Product Name :
CD51/CD61 Antibody, anti-human, FITC
Product Type :
Primary antibodies
Host Species :
mouse IgG1κ
Clonality :
monoclonal
Conjugation :
FITC
Antigen Modification :
CD51/CD61
Clone Name :
23C6
Isotype :
Isotype Control Antibody, mouse IgG1
Size :
100 tests in 1 mL
US List Price :
264 USD
Product Description :
Identification and enumeration of CD51/CD61+ cells by flow cytometry
CrossReactivity :
rabbit, chicken
ALTnames :
ITGAV, MSK8, VNRA, VTNR, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, ITGB3
Specificity :
human, other
Concentration :
1:11
Uses :
For research use only
Application Summary :
Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
Storage :
Store protected from light at 2–8 °C. Do not freeze.
company information
Miltenyi Biotec
Friedrich-Ebert-Strae 68
51429 Bergisch Gladbach
51429 Bergisch Gladbach
macs@miltenyibiotec.com
https://www.miltenyibiotec.com1 800 FOR MACS
headquarters: Germany
questions and comments